CHARLES P. PERLIA, M.D.; SYDNEY KOFMAN, M.D.; DEVANABOYINA NAGAMANI, M.D.; SAMUEL G. TAYLOR III, M.D., F.A.C.P.
In the absence of any definitive cure, retardation of tumor growth with prolongation of a comfortable and useful life is a worth while achievement in the treatment of patients with metastatic cancer. In women, carcinoma of the breast is one of the most common forms of malignant disease, with a high incidence of generalized dissemination and long-lasting terminal disability. Any means of producing reasonably prolonged and successful palliation is highly gratifying to both patient and physician. It is the more desirable to the latter if it can be ascribed to a specific antitumor effect of the therapy used. There
PERLIA CP, KOFMAN S, NAGAMANI D, TAYLOR SG. CRITICAL ANALYSIS OF PALLIATION PRODUCED BY ADRENALECTOMY IN METASTATIC CANCER OF THE FEMALE BREAST1. Ann Intern Med. 1956;45:989–1000. doi: 10.7326/0003-4819-45-6-989
Download citation file:
Published: Ann Intern Med. 1956;45(6):989-1000.
Adrenal Disorders, Endocrine and Metabolism, End-of-Life Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use